The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Agile Acquisition Becomes DISA's New Battlefield Advantage
DODNet leaders say 90-day OTA cycles and flexible engineering models are helping DISA deliver capabilities at the speed of cyber threats.
17m watch -
USPIS Uses AI to Advance Criminal Investigations
The U.S. Postal Inspection Service is using AI to uncover crime patterns, support investigations and improve workforce efficiency.
5m watch -
Advice for the Next Generation of Cybersecurity Professionals
Author Agathe Merle discussed breaking barriers in cybersecurity, fostering inclusion and using creativity to strengthen cyber defense.
29m watch -
How Army Contracting Command is Using AI in Acquisition
Army Contracting Command’s Jordan Duke discusses AI adoption, cybersecurity risks and securing acquisition operations across the Army enterprise.
9m listen
